Abstract
Introduction
Positive airway pressure (PAP) and non-invasive ventilation (NIV) are commonly used in the treatment of varied sleep disorders. While the efficacy of these devices at improving sleep-disordered breathing has been demonstrated, they may also improve other parameters of long-term health including cardiovascular and metabolic disorders. This paper reviews the most recent salient clinical trial and society guideline recommendations in relation to PAP and NIV treatment of sleep-disordered breathing.
Methodology
We searched PubMeb for articles between January 2017 and March 2019. We searched for different PAP and NIV modalities by name, different sleep disorders by name, and combinations thereof [e.g., CPAP, obstructive sleep apnea (OSA), and CPAP + OSA]. As well, we reviewed the most recent society guidelines with regard to PAP and NIV for sleep disorders.
Results
The original search resulted in 3110 articles published over this time period. Additional search limitations included the English language, clinical trials, and society guidelines. This decreased the number of articles to 161 which were reviewed for relevance, and ultimately 38 articles were selected.
Summary
Recent research in the field of PAP and NIV for the treatment of sleep disorders has looked at the benefits of therapy beyond the treatment of daytime sleepiness. Prospective randomized data is still lacking to show reduction in all-cause mortality and cardiovascular events in OSA treated with PAP, although observational data does show a reduction in all-cause mortality in treated severe OSA. Given the results of the SERVE-HF trial in 2015, a great deal of work is ongoing to elucidate the role of NIV in patients with concomitant heart failure and central sleep apnea. Additional studies have compared varied treatment modalities in patients with obesity hypoventilation with and without OSA. As well, new modes of ventilation offer promise for improved sleep parameters and compliance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AASM:
-
American Academy of Sleep Medicine
- AHI:
-
Apnea–hypopnea index
- APAP:
-
Automatic positive airway pressure
- ASV:
-
Adaptive servo-ventilation
- BNP:
-
Brain natriuretic peptide
- BPAP:
-
Bilevel positive airway pressure
- CAD:
-
Coronary artery disease
- CHF:
-
Congestive heart failure
- CKD:
-
Chronic kidney disease
- CMT:
-
Conservative medical therapy
- COPD:
-
Chronic obstructive pulmonary disease
- CPAP:
-
Continuous positive airway pressure
- CSA:
-
Central sleep apnea
- EF:
-
Ejection fraction
- EPAP:
-
Expiratory positive airway pressure
- mIBG:
-
I-metaiodobenzylguanidine
- NIV:
-
Noninvasive ventilation
- OHS:
-
Obesity hypoventilation syndrome
- OSA:
-
Obstructive sleep apnea
- PAP:
-
Positive airway pressure
- PSG:
-
Polysomnogram
- SDB:
-
Sleep-disordered breathing
- T2D:
-
Type 2 diabetes mellitus
- VAPS:
-
Volume-assured pressure support
References
Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine systematic review, meta-analysis, and grade assessment. J Clin Sleep. 2019;15(2):301–34.
Glantz H, Johansson MC, Thunström E, et al. Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: a randomized controlled trial. Int J Cardiol. 2017;241:12–8.
de Souza F, Muxfeldt ES, Margallo V, et al. Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial. J Hypertens. 2017;35(4):837–44.
Chang Y-S, Yee BJ, Hoyos CM, et al. The effects of continuous positive airway pressure therapy on troponin-T and N-terminal pro B-type natriuretic peptide in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med. 2017;39:8–13.
Lam JCM, Lai AYK, Tam TCC, et al. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep Breath. 2017;21(2):377–86.
Morariu EM, Chasens ER, Strollo PJ, et al. Effect of continuous positive airway pressure (CPAP) on glycemic control and variability in type 2 diabetes. Sleep Breath. 2017;21(1):145–7.
Zhao YY, Wang R, Gleason KJ, et al. Effect of continuous positive airway pressure treatment on health-related quality of life and sleepiness in high cardiovascular risk individuals with sleep apnea: Best Apnea Interventions for Research (BestAIR) trial. Sleep. 2017; 40(4).
Yu J, Zhou Z, McEvoy RD, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA. 2017;318(2):156–66.
Lisan Q, Van Sloten T, Marques Vidal P, et al. Association of positive airway pressure prescription with mortality in patients with obesity and severe obstructive sleep apnea: the sleep heart health study. JAMA Otolaryngol Head Neck Surg. 2019;145(6):509–15.
Campos-Rodriguez F, Gonzalez-Martinez M, Sanchez-Armengol A, et al. Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea. Eur Respir J. 2017; 50(2).
Luyster FS, Strollo PJ, Thunström E, et al. Long-term use of continuous positive airway pressure therapy in coronary artery disease patients with nonsleepy obstructive sleep apnea. Clin Cardiol. 2017;40(12):1297–302.
Randerath W, Bassetti CL, Bonsignore MR, et al. Challenges and perspectives in obstructive sleep apnoea: report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society. Eur Respir J. 2018;52(3).
Bloch KE, Huber F, Furian M, et al. Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial. Thorax. 2018;73(2):174–84.
Marrone O, Cibella F, Pépin J-L, et al. Fixed but not autoadjusting positive airway pressure attenuates the time-dependent decline in glomerular filtration rate in patients with OSA. Chest. 2018;154(2):326–34.
Gagnadoux F, Pevernagie D, Jennum P, et al. Validation of the system one RemStar auto A-flex for obstructive sleep apnea treatment and detection of residual apnea-hypopnea index: a European randomized trial. J Clin Sleep Med. 2017;13(2):283–90.
Howard ME, Piper AJ, Stevens B, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax. 2017;72(5):437–44.
Corral J, Mogollon MV, Sánchez-Quiroga M-Á, et al. Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome. Thorax. 2018;73(4):361–8.
Masa JF, Mokhlesi B, Benítez I, et al. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial. Lancet. 2019;393(10182):1721–32.
Orfanos S, Jaffuel D, Perrin C, et al. Switch of noninvasive ventilation (NIV) to continuous positive airway pressure (CPAP) in patients with obesity hypoventilation syndrome: a pilot study. BMC Pulm Med. 2017;17(1):50.
Aurora RN, Chowdhuri S, Ramar K, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep. 2012;35(1):17–40.
Knitter J, Bailey OF, Poongkunran C, et al. Comparison of physiological performance of four adaptive servo ventilation devices in patients with complex sleep apnea. Am J Respir Crit Care Med. 2019;199(7):925–8.
Woehrle H, Cowie MR, Eulenburg C, et al. Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis. Eur Respir J. 2017;50(2).
O’Connor CM, Whellan DJ, Fiuzat M, et al. Cardiovascular outcomes with minute ventilation-targeted adaptive servo-ventilation therapy in heart failure: the CAT-HF trial. J Am Coll Cardiol. 2017;69(12):1577–87.
Yoshida M, Ando S-I, Kodama K, et al. Adaptive servo-ventilation therapy reduces hospitalization rate in patients with severe heart failure. Int J Cardiol. 2017;238:173–6.
Piccini JP, Pokorney SD, Anstrom KJ, et al. Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea. Heart Rhythm. 2019;16(1):91–7.
Daubert MA, Whellan DJ, Woehrle H, et al. Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: insights from the CAT-HF Trial. Am Heart J. 2018;201:40–8.
Hetland A, Lerum TV, Haugaa KH, et al. Patients with Cheyne–Stokes respiration and heart failure: patient tolerance after three-month discontinuation of treatment with adaptive servo-ventilation. Heart Vessels. 2017;32(8):909–15.
Hiasa G, Okayama H, Hosokawa S, et al. Beneficial effects of adaptive servo-ventilation therapy on readmission and medical costs in patients with chronic heart failure. Heart Vessels. 2018;33(8):859–65.
D’Elia E, Ferrero P, Vittori C, et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep Breath. 2019;23(1):287–91.
Tokuda Y, Sakakibara M, Yoshinaga K, et al. Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination of 11C-HED PET and 123I-MIBG SPECT. J Nucl Cardiol. 2019;26(4):1079–89.
Toyama T, Hoshizaki H, Kasama S, et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. J Nucl Cardiol. 2017;24(6):1926–37.
Gunn S, Naik S, Bianchi MT, et al. Estimation of adaptive ventilation success and failure using polysomnogram and outpatient therapy biomarkers. Sleep. 2018;41(9).
Berry RB, Chediak A, Brown LK, et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med. 2010;6(5):491–509.
Royer CP, Schweiger C, Manica D, et al. Efficacy of bilevel ventilatory support in the treatment of stable patients with obesity hypoventilation syndrome: systematic review and meta-analysis. Sleep Med. 2019;53:153–64.
Huang XA, Du YP, Li LX, et al. Comparing the effects and compliance between volume-assured and pressure support non-invasive ventilation in patients with chronic respiratory failure. Clin Respir J. 2019;13(5):289–98.
McArdle N, Rea C, King S, et al. Treating chronic hypoventilation with automatic adjustable versus fixed EPAP intelligent volume-assured positive airway pressure support (iVAPS): a randomized controlled trial. Sleep. 2017;40(10).
Zou C, Sheng W, Huai D, et al. Comparison between auto-trilevel and bilevel positive airway pressure ventilation for treatment of patients with concurrent obesity hypoventilation syndrome and obstructive sleep apnea syndrome. Sleep Breath. 2019;23(3):735–40.
Su M, Huai D, Cao J, et al. Auto-trilevel versus bilevel positive airway pressure ventilation for hypercapnic overlap syndrome patients. Sleep Breath. 2018;22(1):65–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
LeMaster, W.B., Ryden, A., Chang, M., Zeidler, M. (2020). Advances in Positive Pressure Therapy and Noninvasive Ventilation in the Treatment of Sleep Disorders. In: Esquinas, A.M., et al. Noninvasive Ventilation in Sleep Medicine and Pulmonary Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-42998-0_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-42998-0_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42997-3
Online ISBN: 978-3-030-42998-0
eBook Packages: MedicineMedicine (R0)